Why This Meme Stock Isn't Worth the Trouble

One of the more fascinating storylines of this year in the investing world has been the rise of so-called meme stocks. These are companies whose shares have skyrocketed due to interest from investors on social media platforms such as Reddit, sometimes despite the lack of strong financial results or solid fundamentals.

To be fair, not all meme stocks are created equal, and one could make a decent investing case for some of them. But many of these companies are still far too risky for investors focused on the long game to even consider. One that falls squarely in the second category is Ocugen (NASDAQ: OCGN). Although the stock has risen nearly 3,000% over the trailing-12-month period there isn't a solid basis for the growth. Here's why this biotech isn't worth the trouble long-term.

Continue reading


Source Fool.com